
VANI Valuation
Vivani Medical Inc
- Overview
- Forecast
- Valuation
- Earnings
VANI Relative Valuation
VANI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VANI is overvalued; if below, it's undervalued.
Historical Valuation
Vivani Medical Inc (VANI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.39. The fair price of Vivani Medical Inc (VANI) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.16
Fair
-2.90
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Vivani Medical Inc. (VANI) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -1.01. The thresholds are as follows: Strongly Undervalued below -5.37, Undervalued between -5.37 and -3.19, Fairly Valued between 1.17 and -3.19, Overvalued between 1.17 and 3.36, and Strongly Overvalued above 3.36. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-2.81
EV/EBIT
Vivani Medical Inc. (VANI) has a current EV/EBIT of -2.81. The 5-year average EV/EBIT is -2.24. The thresholds are as follows: Strongly Undervalued below -5.13, Undervalued between -5.13 and -3.69, Fairly Valued between -0.80 and -3.69, Overvalued between -0.80 and 0.65, and Strongly Overvalued above 0.65. The current Forward EV/EBIT of -2.81 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Vivani Medical Inc. (VANI) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Vivani Medical Inc. (VANI) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.51. The thresholds are as follows: Strongly Undervalued below -2.89, Undervalued between -2.89 and -1.70, Fairly Valued between 0.68 and -1.70, Overvalued between 0.68 and 1.87, and Strongly Overvalued above 1.87. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Vivani Medical Inc. (VANI) has a current P/FCF of 0.00. The 5-year average P/FCF is -2.13. The thresholds are as follows: Strongly Undervalued below -8.77, Undervalued between -8.77 and -5.45, Fairly Valued between 1.20 and -5.45, Overvalued between 1.20 and 4.52, and Strongly Overvalued above 4.52. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Vivani Medical Inc (VANI) has a current Price-to-Book (P/B) ratio of 13.88. Compared to its 3-year average P/B ratio of 3.19 , the current P/B ratio is approximately 335.45% higher. Relative to its 5-year average P/B ratio of 3.13, the current P/B ratio is about 342.72% higher. Vivani Medical Inc (VANI) has a Forward Free Cash Flow (FCF) yield of approximately -33.96%. Compared to its 3-year average FCF yield of -33.13%, the current FCF yield is approximately 2.51% lower. Relative to its 5-year average FCF yield of -33.02% , the current FCF yield is about 2.84% lower.
14.00
P/B
Median3y
3.19
Median5y
3.13
-33.96
FCF Yield
Median3y
-33.13
Median5y
-33.02
Competitors Valuation Multiple
The average P/S ratio for VANI's competitors is 3.53, providing a benchmark for relative valuation. Vivani Medical Inc Corp (VANI) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of VANI increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of VANI in the past 1 year is driven by Unknown.
People Also Watch

NSPR
InspireMD Inc
2.430
USD
0.00%

LSF
Laird Superfood Inc
5.770
USD
+1.23%

PMVP
PMV Pharmaceuticals Inc
1.550
USD
+4.03%

CLSD
Clearside Biomedical Inc
0.340
USD
+0.29%

BNR
Burning Rock Biotech Ltd
8.230
USD
+4.97%

XGN
Exagen Inc
9.680
USD
+0.73%

OPTX
Syntec Optics Holdings Inc
1.580
USD
+1.28%

LODE
Comstock Inc
2.370
USD
-0.84%

FUSB
First US Bancshares Inc
11.000
USD
-2.91%
FAQ

Is Vivani Medical Inc (VANI) currently overvalued or undervalued?
Vivani Medical Inc (VANI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.39. The fair price of Vivani Medical Inc (VANI) is between to according to relative valuation methord.

What is Vivani Medical Inc (VANI) fair value?

How does VANI's valuation metrics compare to the industry average?

What is the current P/B ratio for Vivani Medical Inc (VANI) as of Sep 03 2025?

What is the current FCF Yield for Vivani Medical Inc (VANI) as of Sep 03 2025?

What is the current Forward P/E ratio for Vivani Medical Inc (VANI) as of Sep 03 2025?
